Success Stories: EB1B Success Achieved with NAILG’s Guidance for Research Associate in Biochemistry

Client’s Testimonial:

“This is great news! I do appreciate all the dedicated work you have done. Thank you very much!!”

On February 26^th, 2025, we received another EB1B (Outstanding Professor/Researcher) approval for a Research Associate in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Research Associate

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: February 26^th, 2025

Processing Time: 20 days (Premium Processing Requested)

Case Summary:

North America Immigration Law Group (NAILG) is proud to share the EB1B approval of a distinguished biochemist whose work in structural biology and immunology is driving progress in understanding and treating some of the nation’s most pressing health challenges. His research focuses on antimicrobial proteins, lipid-binding proteins, offering valuable insights into immune response and the mechanisms of inflammatory diseases such as Alzheimer’s Disease (AD) and Inflammatory Bowel Disease (IBD).

Our client is particularly recognized for several groundbreaking studies that have advanced the field. His investigation into the effect of calcitonin gene-related peptides in ischemic injuries was the first of its kind, while his discovery of the dimeric form of adipocyte fatty acid-binding proteins opened new avenues for understanding lipid metabolism. In addition, his pioneering measurement of Solid State NMR chemical shifts and his novel interpretation of the allosteric effect of calcium binding on zinc-binding at the atomic level have significantly influenced ongoing biochemical research.

The strength of his record reflects a career of sustained contributions and recognition:

9 peer-reviewed journal articles, including 6 first-authored, 1 authored book chapter.
132 citations in peer-reviewed publications.
Research supported by the U.S. National Institutes of Health (NIH) and the U.S. National Science Foundation (NSF).
At least 40 peer reviews completed for respected journals.

His peers have underscored the importance of his work:

“As [Client]’s work aligns with the national efforts to illuminate the body’s response to pathogenic attacks and to develop new drugs for their treatment, it is important that it continue without interruption. Put simply, [Client]’s outstanding research is precisely the work that we are in need of in the biochemistry research community.”

By thoroughly analyzing our client’s achievements and strategically framing his record of publications, citations, federal funding support, and extensive peer-review service, NAILG crafted a persuasive petition that clearly demonstrated his indispensable role in advancing biochemistry and immunology. Our team highlighted how his pioneering studies directly align with U.S. priorities in combating inflammatory and neurodegenerative diseases. Thanks to NAILG’s careful preparation and advocacy, USCIS approved his EB1B petition, affirming that his ongoing research will play a vital role in strengthening the nation’s leadership in biomedical innovation and therapeutic discovery.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.